Astellas Pharma Inc.
2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-8411, Japan
Headquarters Access Map (Google Maps)
Headquarters Annex Access Map (Google Maps)
103,001 million yen (March 2021)
Kenji Yasukawa (President and Chief Executive Officer)
15,455 (Consolidated basis, March 2021)
Manufacturing, marketing and import/export of pharmaceuticals.
As of April 1, 2021
What “Astellas” means?
In April 2005, two pharmaceutical companies, Yamanouchi and Fujisawa, were merged to form Astellas Pharma Inc. The companies were joined to realize an ambitious idea—the creation of a new company that would be fully competitive both in Japan and across the world. That ambition was rewarded as today, Astellas is a global company with a core business in prescription drugs.
"Astellas" is derived from the Greek word "aster," the Latin word "stella," and the English word "stellar," all meaning "star," and the name carries a meaning akin to "aspired stars" or "advanced stars." "Astellas" also draws on a Japanese phrase that translates as "illuminate tomorrow." This phrase expresses our commitment to develop as an R&D-oriented company focused on providing a healthier tomorrow for all through cutting-edge pharmaceuticals.